Dyne Therapeutics IncNASDAQ:DYN
- LAST PRICE11.5600
- TODAY'S CHANGE (%)0.1400 (1.2259%)
- Bid / Lots9.7000/ 1
- Ask / Lots13.0000/ 10
- Open / Previous Close11.5000 / 11.4200
- Day Range
- 52 Week Range
- Volume428,385
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DYN |
|---|---|---|
| 09:32 ET | 1465 | 11.55 |
| 09:33 ET | 100 | 11.33 |
| 09:39 ET | 100 | 11.325 |
| 09:42 ET | 2200 | 11.53 |
| 09:44 ET | 2100 | 11.34 |
| 09:46 ET | 100 | 11.38 |
| 09:48 ET | 100 | 11.41 |
| 09:50 ET | 800 | 11.475 |
| 09:51 ET | 897 | 11.565 |
| 09:53 ET | 300 | 11.59 |
| 09:55 ET | 3394 | 11.56 |
| 09:57 ET | 100 | 11.52 |
| 10:00 ET | 200 | 11.54 |
| 10:02 ET | 867 | 11.55 |
| 10:04 ET | 300 | 11.47 |
| 10:08 ET | 500 | 11.43 |
| 10:09 ET | 746 | 11.37 |
| 10:11 ET | 300 | 11.33 |
| 10:13 ET | 100 | 11.31 |
| 10:15 ET | 232 | 11.3 |
| 10:18 ET | 200 | 11.345 |
| 10:20 ET | 400 | 11.42 |
| 10:22 ET | 200 | 11.49 |
| 10:24 ET | 4000 | 11.47 |
| 10:26 ET | 1401 | 11.39 |
| 10:27 ET | 1500 | 11.38 |
| 10:29 ET | 100 | 11.41 |
| 10:31 ET | 577 | 11.39 |
| 10:33 ET | 200 | 11.44 |
| 10:36 ET | 1900 | 11.4 |
| 10:38 ET | 1100 | 11.46 |
| 10:40 ET | 200 | 11.46 |
| 10:42 ET | 2459 | 11.395 |
| 10:44 ET | 200 | 11.4 |
| 10:47 ET | 100 | 11.38 |
| 10:49 ET | 400 | 11.31 |
| 10:51 ET | 200 | 11.29 |
| 10:54 ET | 1328 | 11.37 |
| 10:56 ET | 400 | 11.425 |
| 10:58 ET | 300 | 11.455 |
| 11:03 ET | 4735 | 11.32 |
| 11:05 ET | 2300 | 11.36 |
| 11:07 ET | 1072 | 11.29 |
| 11:09 ET | 100 | 11.28 |
| 11:12 ET | 470 | 11.3 |
| 11:14 ET | 100 | 11.31 |
| 11:18 ET | 200 | 11.26 |
| 11:20 ET | 400 | 11.23 |
| 11:21 ET | 820 | 11.27 |
| 11:25 ET | 300 | 11.23 |
| 11:27 ET | 500 | 11.255 |
| 11:30 ET | 5386 | 11.19 |
| 11:32 ET | 400 | 11.2 |
| 11:36 ET | 1300 | 11.205 |
| 11:38 ET | 4100 | 11.21 |
| 11:39 ET | 3600 | 11.18 |
| 11:41 ET | 400 | 11.24 |
| 11:43 ET | 500 | 11.2414 |
| 11:54 ET | 200 | 11.27 |
| 11:56 ET | 1000 | 11.245 |
| 11:57 ET | 300 | 11.23 |
| 12:01 ET | 100 | 11.22 |
| 12:03 ET | 26975 | 11.3 |
| 12:06 ET | 23061 | 11.35 |
| 12:08 ET | 600 | 11.35 |
| 12:10 ET | 300 | 11.32 |
| 12:12 ET | 600 | 11.345 |
| 12:14 ET | 200 | 11.37 |
| 12:15 ET | 300 | 11.31 |
| 12:17 ET | 100 | 11.3 |
| 12:19 ET | 403 | 11.33 |
| 12:21 ET | 300 | 11.31 |
| 12:24 ET | 300 | 11.33 |
| 12:26 ET | 100 | 11.33 |
| 12:28 ET | 1200 | 11.33 |
| 12:30 ET | 1674 | 11.29 |
| 12:32 ET | 400 | 11.295 |
| 12:33 ET | 300 | 11.285 |
| 12:37 ET | 787 | 11.35 |
| 12:42 ET | 100 | 11.35 |
| 12:46 ET | 100 | 11.39 |
| 12:48 ET | 436 | 11.415 |
| 12:50 ET | 209 | 11.4 |
| 12:53 ET | 100 | 11.39 |
| 12:55 ET | 200 | 11.39 |
| 01:02 ET | 756 | 11.39 |
| 01:04 ET | 319 | 11.4 |
| 01:06 ET | 1813 | 11.41 |
| 01:08 ET | 500 | 11.41 |
| 01:09 ET | 1170 | 11.435 |
| 01:11 ET | 2646 | 11.46 |
| 01:13 ET | 100 | 11.44 |
| 01:15 ET | 100 | 11.47 |
| 01:18 ET | 500 | 11.45 |
| 01:22 ET | 600 | 11.44 |
| 01:24 ET | 5653 | 11.48 |
| 01:26 ET | 150 | 11.52 |
| 01:27 ET | 227 | 11.5 |
| 01:29 ET | 366 | 11.53 |
| 01:31 ET | 200 | 11.51 |
| 01:33 ET | 400 | 11.49 |
| 01:36 ET | 200 | 11.47 |
| 01:38 ET | 100 | 11.45 |
| 01:40 ET | 16200 | 11.49 |
| 01:42 ET | 100 | 11.51 |
| 01:44 ET | 2571 | 11.5 |
| 01:45 ET | 404 | 11.49 |
| 01:47 ET | 601 | 11.47 |
| 01:49 ET | 601 | 11.495 |
| 01:51 ET | 200 | 11.48 |
| 01:54 ET | 1501 | 11.52 |
| 01:56 ET | 227 | 11.51 |
| 01:58 ET | 100 | 11.51 |
| 02:00 ET | 1000 | 11.5 |
| 02:02 ET | 201 | 11.505 |
| 02:03 ET | 206 | 11.485 |
| 02:05 ET | 1570 | 11.47 |
| 02:07 ET | 900 | 11.465 |
| 02:09 ET | 500 | 11.48 |
| 02:12 ET | 591 | 11.485 |
| 02:14 ET | 207 | 11.485 |
| 02:16 ET | 200 | 11.47 |
| 02:18 ET | 900 | 11.5 |
| 02:20 ET | 400 | 11.52 |
| 02:21 ET | 300 | 11.52 |
| 02:23 ET | 100 | 11.52 |
| 02:25 ET | 113 | 11.52 |
| 02:27 ET | 400 | 11.52 |
| 02:30 ET | 300 | 11.5 |
| 02:32 ET | 200 | 11.5 |
| 02:34 ET | 200 | 11.51 |
| 02:36 ET | 100 | 11.51 |
| 02:38 ET | 1684 | 11.53 |
| 02:39 ET | 2114 | 11.58 |
| 02:41 ET | 100 | 11.55 |
| 02:43 ET | 111 | 11.55 |
| 02:45 ET | 200 | 11.53 |
| 02:48 ET | 1319 | 11.52 |
| 02:50 ET | 100 | 11.5 |
| 02:52 ET | 538 | 11.53 |
| 02:56 ET | 200 | 11.51 |
| 02:57 ET | 100 | 11.51 |
| 02:59 ET | 5830 | 11.545 |
| 03:01 ET | 200 | 11.53 |
| 03:03 ET | 300 | 11.54 |
| 03:06 ET | 1220 | 11.55 |
| 03:08 ET | 2467 | 11.57 |
| 03:10 ET | 500 | 11.55 |
| 03:14 ET | 302 | 11.54 |
| 03:15 ET | 100 | 11.54 |
| 03:17 ET | 407 | 11.56 |
| 03:21 ET | 1000 | 11.54 |
| 03:24 ET | 518 | 11.53 |
| 03:26 ET | 400 | 11.52 |
| 03:28 ET | 600 | 11.51 |
| 03:30 ET | 2805 | 11.5 |
| 03:32 ET | 400 | 11.52 |
| 03:33 ET | 2627 | 11.53 |
| 03:35 ET | 464 | 11.55 |
| 03:37 ET | 471 | 11.54 |
| 03:39 ET | 2745 | 11.5 |
| 03:42 ET | 1491 | 11.53 |
| 03:44 ET | 951 | 11.52 |
| 03:46 ET | 510 | 11.52 |
| 03:48 ET | 1919 | 11.51 |
| 03:50 ET | 460 | 11.51 |
| 03:51 ET | 2254 | 11.55 |
| 03:53 ET | 2201 | 11.55 |
| 03:55 ET | 6417 | 11.58 |
| 03:57 ET | 22804 | 11.56 |
| 04:00 ET | 14530 | 11.56 |
Nov 7, 2023
Dyne Therapeutics to Present at November Investor Conferences, from 7:30AM ET on Tuesday Nov 07, 2023 by Dow Jones
7:30AM ET on Tuesday Nov 07, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dyne Therapeutics Inc | 700.9M | -3.2x | --- |
Hillevax Inc | 697.0M | -5.3x | --- |
ACELYRIN Inc | 666.8M | 0.0x | --- |
WAVE Life Sciences Ltd | 680.5M | -5.6x | --- |
Cogent Biosciences Inc | 740.7M | -3.7x | --- |
Biomea Fusion Inc | 658.8M | -4.5x | --- |
Company Information
Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that it has designed to target the genetic basis of the disease. Using its FORCE platform, the Company is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. The Company also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.
Contact Information
- Headquarters
- 1560 Trapelo RoadWALTHAM, MA, United States 02451
- Phone
- 781-786-8230
- Fax
- 781-786-8866
Executives
- Independent Chairman of the Board
- Jason Rhodes
- President, Chief Executive Officer, Director
- Joshua Brumm
- Chief Operating Officer
- Susanna High
- Senior Vice President - Business Development
- Jonathan McNeill
- Senior Vice President, Head of Finance and Administration
- Richard Scalzo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $700.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.59 |
Book Value | $4.54 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
